Literature DB >> 28723703

Management of chest pain in the French emergency healthcare system: the prospective observational EPIDOULTHO study.

Sandrine Charpentier1,2, Sebastien Beaune3,4, Luc Marie Joly5, Abdo Khoury6,7, François-Xavier Duchateau8,9,10, Raphael Briot11, Bertrand Renaud12, François-Xavier Ageron13,14.   

Abstract

OBJECTIVE: The aim of this paper was to describe the epidemiology, and diagnostic and therapeutic strategies that emergency physicians use to manage patients presenting with chest pain at all three levels of the French emergency medical system - that is, dispatch centres (SAMUs: the medical emergency system), which operate the mobile intensive care units (MICUs), and hospitals' emergency departments (EDs), with a focus on acute coronary syndrome (ACS). PATIENTS AND METHODS: All patients with chest pain who contacted a SAMU and/or were managed by a MICU and/or were admitted into an ED were included in a 1-day multicentre prospective study carried out in January 2013. Data on diagnostic and therapeutic management and disposition were collected. An in-hospital follow-up was performed.
RESULTS: In total, 1339 patients were included: 537 from SAMU, 187 attended by a MICU and 615 in EDs. Diagnosing ACS was the main diagnostic strategy of the French emergency care system, diagnosed in 16% of SAMU patients, 25% of MICU patients and 10% of ED patients. Among patients calling the SAMU, 76 (14%) received only medical advice, 15 (8%) patients remained at home after being seen by a MICU and 454 (74%) were discharged from an ED.
CONCLUSION: Management of chest pain at the three levels of the French medical emergency system is mainly oriented towards ruling out ACS. The strategy of diagnostic management is based on minimizing missed diagnoses of ACS.

Entities:  

Mesh:

Year:  2018        PMID: 28723703     DOI: 10.1097/MEJ.0000000000000481

Source DB:  PubMed          Journal:  Eur J Emerg Med        ISSN: 0969-9546            Impact factor:   2.799


  6 in total

1.  Intensity of care delivered by prehospital emergency medical service physicians to patients with deliberate self-poisoning: results from a 2-day cross-sectional study in France.

Authors:  Maxime Maignan; Damien Viglino; Roselyne Collomb Muret; Nathan Vejux; Eric Wiel; Laurent Jacquin; Said Laribi; Papa N-Gueye; Luc-Marie Joly; Florence Dumas; Sebastien Beaune
Journal:  Intern Emerg Med       Date:  2019-05-18       Impact factor: 3.397

Review 2.  Collateral damage of the COVID-19 outbreak: expression of concern.

Authors:  Anne-Laure Feral-Pierssens; Pierre-Géraud Claret; Tahar Chouihed
Journal:  Eur J Emerg Med       Date:  2020-08       Impact factor: 4.106

3.  Predicting acute coronary syndrome in males and females with chest pain who call an emergency medical communication centre.

Authors:  Paul-Georges Reuter; Catherine Pradeau; Samantha Huo Yung Kai; Thibault Lhermusier; Arnaud Bourdé; Eric Tentillier; Xavier Combes; Vanina Bongard; Jean-Louis Ducassé; Sandrine Charpentier
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2019-10-17       Impact factor: 2.953

4.  Patterns of Emergency Care for Possible Acute Coronary Syndrome Among Patients with Chest Pain or Shortness of Breath at a Tanzanian Referral Hospital.

Authors:  Julian T Hertz; Godfrey L Kweka; Gerald S Bloomfield; Alexander T Limkakeng; Zak Loring; Gloria Temu; Blandina T Mmbaga; Charles J Gerardo; Francis M Sakita
Journal:  Glob Heart       Date:  2020-02-06

5.  Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

Authors:  Enrico Ammirati; Maria Frigerio; Leslie T Cooper; Paolo G Camici; Eric D Adler; Cristina Basso; David H Birnie; Michela Brambatti; Matthias G Friedrich; Karin Klingel; Jukka Lehtonen; Javid J Moslehi; Patrizia Pedrotti; Ornella E Rimoldi; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Circ Heart Fail       Date:  2020-11-12       Impact factor: 8.790

6.  A New Risk Score for Patients With Acute Chest Pain and Normal High Sensitivity Troponin.

Authors:  Chunpeng Ma; Xiaoli Liu; Lixiang Ma
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.